Catline Nobre
4PUBLICATIONS
108CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé
|Sep 24, 2025
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers.Michael Hulse, Min Wang, Chaoyi Xu
|Sep 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul
|Sep 03, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.Francesco Facchinetti, Yohann Loriot, Floriane Brayé
Pageof 1
Frequent Collaborators
4 joint publications
Ludovic Bigot
3 joint publications
Luc Friboulet
2 joint publications
Francesco Facchinetti
2 joint publications
Yohann Loriot
2 joint publications
Floriane Brayé
2 joint publications
Damien Vasseur
2 joint publications
Rémy Barbé
2 joint publications
Lambros Tselikas
2 joint publications
Antoine Italiano
2 joint publications
Cristina Smolenschi
